Dash Acquisitions Inc. Abbott Laboratories Transaction History

Dash Acquisitions Inc.

$495 Million
Q3 2025

A detailed history of Dash Acquisitions Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Dash Acquisitions Inc. holds 105,719 shares of ABT stock, worth $13.7 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares

105,719

Previous 103,046 2.59%

Holding current value

$13.7 Million

Previous $14 Million 1.03%

% of portfolio

2.86%

Previous 2.98%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$120.51 - $136.62 $322,123 - $365,185	2,673 Added 2.59%	105,719 $14.2 Million
Q2 2025 Jul 28, 2025	SELL	$123.95 - $138.08 $123,330 - $137,389	-995 Reduced 0.96%	103,046 $14 Million
Q1 2025 May 14, 2025	SELL	$111.1 - $140.22 $1.85 Million - $2.33 Million	-16,631 Reduced 13.78%	104,041 $13.8 Million
Q4 2024 Feb 03, 2025	BUY	$111.93 - $119.39 $97,491 - $103,988	871 Added 0.73%	120,672 $13.6 Million
Q3 2024 Oct 28, 2024	BUY	$100.07 - $118.13 $615,030 - $726,026	6,146 Added 5.41%	119,801 $13.7 Million

Q2 2024 Jul 18, 2024	BUY	$100.73 - $112.44 $1.09 Million - $1.21 Million	10,776 Added 10.47%	113,655 $11.8 Million
Q1 2024 Apr 18, 2024	BUY	$109.52 - $120.96 $404,019 - $446,221	3,689 Added 3.72%	102,879 $11.7 Million
Q4 2023 Jan 17, 2024	BUY	$90.19 - $110.4 $246,489 - $301,723	2,733 Added 2.83%	99,190 $10.9 Million
Q3 2023 Oct 13, 2023	BUY	$95.53 - $114.62 $187,716 - $225,228	1,965 Added 2.08%	96,457 $9.34 Million
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $763,206 - $850,372	7,573 Added 8.71%	94,492 $10.3 Million
Q1 2023 Apr 05, 2023	BUY	$96.86 - $114.01 $641,310 - $754,860	6,621 Added 8.25%	86,919 $8.8 Million
Q4 2022 Jan 17, 2023	SELL	$95.06 - $111.52 $451,915 - $530,166	-4,754 Reduced 5.59%	80,298 $0
Q3 2022 Nov 22, 2022	BUY	$96.76 - $112.03 $494,540 - $572,585	5,111 Added 6.39%	85,052 $8.23 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $100,436 - $121,396	984 Added 1.25%	79,941 $8.69 Million
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $529,622 - $645,840	4,645 Added 6.25%	78,957 $9.35 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $698,494 - $855,267	6,046 Added 8.86%	74,312 $10.5 Million
Q3 2021 Nov 08, 2021	BUY	$116.66 - $129.06 $696,693 - $770,746	5,972 Added 9.59%	68,266 $8.06 Million
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $440,403 - $518,418	4,163 Added 7.16%	62,294 $7.22 Million
Q1 2021 Apr 20, 2021	BUY	$108.84 - $128.23 $2.78 Million - $3.27 Million	25,540 Added 78.37%	58,131 $6.97 Million
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $3.42 Million - $3.73 Million	32,591 New	32,591 $3.57 Million

Others Institutions Holding ABT

# of Institutions

3,651

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dash Acquisitions Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dash Acquisitions Inc. with notifications on news.

Account

Dash Acquisitions Inc. Abbott Laboratories Transaction History